---
document_datetime: 2023-09-21 17:12:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/arepanrix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: arepanrix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2484175
conversion_datetime: 2025-12-28 20:09:21.056961
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

## Arepanrix

Procedural steps taken and scientific information after the authorisation

| No      | Scope                                                                                                                                                                                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3 Summary   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|------------------------------------------|
| IB/0007 | Administrative: correction                                                                                                                                                                                                                 | 22/11/2010                          | n/a                                         |                                          |
| IA/0001 | Administrative: correction                                                                                                                                                                                                                 | 19/11/2010                          | n/a                                         | Annex II longer                          |
| IB/0005 | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.f.1.a.1 - Stability of FP - Reduction of the shelf life of the finished product - As packaged for sale | 13/08/2010                          | n/a product no                              | SPC                                      |

<!-- image -->

Medicinal product no longer authorised

2 No Commission Decision is issued for type IA and type IB variations or for type II variations and annual re-assessments that do not affect the annexes.

3 SPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom

Telephone

+44 (0)20 7418 8400

Facsimile

+44 (0) 20 7523 7455

E-mail

info@ema.europa.eu Website www.ema.europa.eu

<!-- image -->